Sarah_Excited
Neurologist
I am a person with Parkinson's.
Peter_Susan_Happy_iPad
Neurologist
I am a caregiver or loved one.
Neurologist_Female_Circular
Neurologist
I am a neurologist or Parkinson's nurse.
Movement_Specialist_Female2
Neurologist
I am a physical therapist or a movement disorder specialist.
Hospital
Neurologist
I am an organization that provides healthcare services.
Researcher_Circular
Neurologist
I am a pharmaceutical company or a clinical research organization.
Payer
Neurologist
I am a public or private payer.
Investor
Neurologist

Neurologist, Parkinson's nurse

Neurologist_Female_Circular
Neurologist or Parkinson's nurse
"I only see my patients a few times per year for a short time. I must rely on what they tell me and on what I see during the consultation. This is not always representative of how they feel at home. I can’t track whether they have followed my treatment advice that I gave them six months ago."
With NeuroPath Insights, you have access to comprehensive information from your patients. This can help you identify patterns in their daily activities and trends in the progression of the disease and gain a better understanding of how they are adhering and responding to the treatment."
“Talking with the patient is much more efficient now since I can see – within seconds- what happened during the last period. I can exactly see progress and decline and immediately check the details."
NeuroPath can help you provide integrated care and communicate with other healthcare professionals to ensure that your patient’s needs are being met. By pro-actively working together, you can save time and focus on what is important to your patient. You can use existing reimbursement codes.

Physical therapist, movement disorder specialist

Movement_Specialist_Female2
Physical therapist or movement disorder specialist
"It takes a lot of commitment for people with Parkinson’s to visit their physical therapist as much as they should, let alone the busy schedules of the therapists. Yet exercise is one of the most powerful treatments for Parkinson’s. Physical activity slows the disease process, decreases the pain associated with Parkinson`s disease, prolongs the independent mobility (gait, balance, strength) and improves sleep, mood, memory hence improving the overall quality of life."
NeuroPath offers markerless motion capturing technology that you can use to monitor people with Parkinson’s' movements in real-time, whether they are in hospital, at home or at your office. This allows you to analyze movement parameters and provide immediate feedback. In addition, NeuroPath uses the information from Apple’s Movement Disorder Symptom Monitoring on the Apple Watch and from the Apple HealthKit."
“Leveraging its markerless motion capturing technology, NeuroPath enables us to accurately analyze and track patients' movements, empowering us to fine-tune their therapy plans and optimize their progress for better outcomes.“
In between therapy sessions, people with Parkinson’s can record themselves at home whilst doing their exercises. The results are immediately uploaded to your platform. You can tailor their physical exercise regimen to their specific needs and progress. Whilst tracking movement parameters over time, you can adjust the exercises accordingly, ensuring that they are getting the most out of their physical therapy sessions.

Organization that provides healthcare services

Hospital
Organization that provides healthcare services
"Parkinson’s is a very complex disease requiring personalized care.

The comprehensive care required can be time-consuming and limited resources can hinder the delivery of optimal care and support for individuals with Parkinson's."
NeuroPath helps you with better care management. We offer the possibility to people with Parkinson’s to communicate with their healthcare providers in real-time. This ensures that people with Parkinson’s receive appropriate care and timely interventions before their conditions worsen, thus resulting in better outcomes.
“The use of NeuroPath can help avoid adverse events such as falls, fractures, hospitalizations, emergency room admissions, and untreated co-morbidities. The significant costs associated with these events can thus be reduced.“
The NHS RightCare methodology shows the implications – both in terms of quality of life and costs – of shifting the care pathway of people with Parkinson’s from a reactive approach (primarily based on an acute response) to a proactive approach, e.g. providing an integrated primary care and community-based response.

This helps clinicians and payers to improve the value and outcomes of the care pathway as part of an overall approach to considering quality of care and health care contracting.

Pharmaceutical company or a clinical research organization

Researcher_Circular
Pharmaceutical company or a clinical research organization
"The main challenge pharmaceutical companies and CRO’s face in dealing with Parkinson's treatment and clinical trials is the complex and heterogeneous nature of the disease. There is no cure today."
NeuroPath provides real world evidence by collecting data from people with Parkinson’s disease in real-time, outside of a controlled clinical environment. This allows for a more comprehensive understanding of the disease and its progression, which can aid in the development of new treatments.
NeuroPath provides you with a valuable tool for the identification and recruiting of people with Parkinson’s, remote monitoring, and the collection of large data sets for research purposes.
The use of the NeuroPath platform leads to a reduction in clinical trial costs, enhanced efficacy of treatment, and more targeted recruiting for trials, ultimately helping to advance our understanding of Parkinson's disease and improve patient care.

Public or private payer

Payer
Public or private payer
"The main problem healthcare payers face in dealing with Parkinson's treatment is the high costs associated with long-term care, management, and unnecessary adverse events, which further increase expenses. The costs of Parkinson's in the US are staggering, with an estimated $52 billion annual spend."
NeuroPath promotes better adherence to treatment plans, better home care, and provides valuable data for improving plans and policies.
Studies have shown that slowing down the progression of Parkinson’s adds significant quality-adjusted life years and cost savings.

“Medicare Advantage (MA) plans, which focus on complex patients, are now a viable place for a 'prevention play'. The exciting part of Medicare Advantages is that it is enabling companies with these technologies to get into patients’ homes and really drive better outcomes."
NeuroPath promotes better care management for people with Parkinson’s. The analysis of patient outcomes and treatment utilization allows you to make data driven decisions. This can reduce unnecessary and costly interventions, leading to significant cost savings for you and to improved outcomes for people with Parkinson’s disease, ultimately benefiting the entire healthcare system.

Investor

Investor
Investor
10 million people are diagnosed with Parkinson’s today and it is the fastest growing neurodegenerative disease.

Every 9 minutes, someone in the U.S. is diagnosed with Parkinson’s disease. 20% are younger than 64.

$ 52 billion in direct and indirect cost are associated with Parkinson’s in the U.S. yearly.

Most people with Parkinson’s (PwP) are underserved.

There is no cure today.